Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KHP Medtech Innovations (KHP Ventures) is a healthcare-focused venture capital firm and strategic investor. It focuses on equity investments into early-stage, high-impact digital health and MedTech startups, particularly those with significant clinical and health system impact. It is a unique collaboration between King's College London, King's College Hospital NHS Foundation Trust, and Guy's and St Thomas' NHS Foundation Trust. KHP Ventures aims to accelerate the development and adoption of healthcare innovations by leveraging academic, clinical, and industry expertise, providing capital, strategic support, and healthcare ecosystem access to portfolio companies. The company does not develop drugs or devices itself, nor does it hold a proprietary pipeline, platform, or therapeutic assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KHP Medtech Innovations.